A research study titled, “Breast Biopsy Devices Market” by Procedure Type, Product, and Guidance Type - Global Industry Analysis and Forecast to 2022” published by Crystal Market Research, states that the Breast Biopsy Devices Market is projected to be around USD 1.03 billion by 2022, while registering itself at a significant compound annual growth rate (CAGR) of 9.39%
Competitive Outlook and Trend Analysis
Some major players in the market are Devicor Medicals Products, Inc, C. R. Bard, Inc., OncoCyte Corporation, Stryker International, Inc., Dickinson and Company (BD), F. Hoffmann-La Roche Ltd., Hologic Inc, and Laboratory Corporation of America Holdings (Labcorp).
Some major players in the market are Devicor Medicals Products, Inc, C. R. Bard, Inc., OncoCyte Corporation, Stryker International, Inc., Dickinson and Company (BD), F. Hoffmann-La Roche Ltd., Hologic Inc, and Laboratory Corporation of America Holdings (Labcorp).
Request Sample Copy @
https://www.crystalmarketresearch.com/report-sample/CM10250
https://www.crystalmarketresearch.com/report-sample/CM10250
Industry Trend Analysis
The Breast Biopsy Device Market was worth USD 0.38 billion in the year 2012 and is expected to reach approximately USD 1.03 billion by 2022, while registering itself at a significant compound annual growth rate (CAGR) of 9.39% during the forecast period. It is a diagnostic method that includes the expulsion of fluid or tissue from a suspicious region. The test needs working with guidance systems, the intent behind which is to detect an abnormality or a lump from the breast area. The varied modalities utilized as controlling systems in the location of breast tumors incorporate the ultrasound, mammography, and magnetic resonance imaging. The ultrasound section is foreseen to witness the quickest development attributable to the increasing requirement of non-radiation biopsies alongside the increasing interest for minimally invasive techniques.
The level of hazard considers the invasiveness of the method utilized. Surgical core methods may be more precise and successful however it includes real dangers. Besides, roughly 60%to 80% of the biopsies acquired are generous. Subsequently, women are urged to take a second opinion before experiencing any such surgical strategies, which thusly is relied upon to contrarily influence the market development.
The Breast Biopsy Device Market was worth USD 0.38 billion in the year 2012 and is expected to reach approximately USD 1.03 billion by 2022, while registering itself at a significant compound annual growth rate (CAGR) of 9.39% during the forecast period. It is a diagnostic method that includes the expulsion of fluid or tissue from a suspicious region. The test needs working with guidance systems, the intent behind which is to detect an abnormality or a lump from the breast area. The varied modalities utilized as controlling systems in the location of breast tumors incorporate the ultrasound, mammography, and magnetic resonance imaging. The ultrasound section is foreseen to witness the quickest development attributable to the increasing requirement of non-radiation biopsies alongside the increasing interest for minimally invasive techniques.
The level of hazard considers the invasiveness of the method utilized. Surgical core methods may be more precise and successful however it includes real dangers. Besides, roughly 60%to 80% of the biopsies acquired are generous. Subsequently, women are urged to take a second opinion before experiencing any such surgical strategies, which thusly is relied upon to contrarily influence the market development.
Regional Outlook and Trend Analysis
North America is accountable for a bigger market share, primarily due to existence of key market players and prompts adoption of enhanced medical technologies, especially in countries like Canada and the U.S. According to a non-profit organization which emphasizes on breast cancer awareness – Susang Komen, in 2015 there were more than 2.3 million breast cancer cases that were diagnosed in the United States alone. Asia Pacific region is anticipated to gain lucrative market during the forecast period. This is due to the increased level of awareness amongst the population, rising disposable income, and large population. International Association of Cancer Registries stated that in 2012, more than 600,000 fresh cases of breast cancer were diagnosed in Asia and that accounted for 39% of overall breast cancers diagnosed across the world. In EU-28 of The European Breast Cancer Coalition, it has been stated that in 2012, 361,600 breast cancer cases were registered. Also, one in every eight women in the EU-28 is expected to acquire breast cancer before the age of 85.
North America is accountable for a bigger market share, primarily due to existence of key market players and prompts adoption of enhanced medical technologies, especially in countries like Canada and the U.S. According to a non-profit organization which emphasizes on breast cancer awareness – Susang Komen, in 2015 there were more than 2.3 million breast cancer cases that were diagnosed in the United States alone. Asia Pacific region is anticipated to gain lucrative market during the forecast period. This is due to the increased level of awareness amongst the population, rising disposable income, and large population. International Association of Cancer Registries stated that in 2012, more than 600,000 fresh cases of breast cancer were diagnosed in Asia and that accounted for 39% of overall breast cancers diagnosed across the world. In EU-28 of The European Breast Cancer Coalition, it has been stated that in 2012, 361,600 breast cancer cases were registered. Also, one in every eight women in the EU-28 is expected to acquire breast cancer before the age of 85.
Browse Full Report @
https://www.crystalmarketresearch.com/report/breast-biopsy-devices-market
https://www.crystalmarketresearch.com/report/breast-biopsy-devices-market
By Region-
Middle East And Africa (Saudi Arabia, UAE, Egypt, Nigeria And South Africa)
North America (U.S, Canada, Mexico)
Europe (Germany, France, UK, Italy, Spain, Rest Of Europe)
Asia-Pacific (Japan, China, Australia, India, South Korea, Rest Of Asia-Pacific)
Rest Of The World (Brazil, South Africa, Saudi Arabia, Turkey, United Arab Emirates, Others)
Middle East And Africa (Saudi Arabia, UAE, Egypt, Nigeria And South Africa)
North America (U.S, Canada, Mexico)
Europe (Germany, France, UK, Italy, Spain, Rest Of Europe)
Asia-Pacific (Japan, China, Australia, India, South Korea, Rest Of Asia-Pacific)
Rest Of The World (Brazil, South Africa, Saudi Arabia, Turkey, United Arab Emirates, Others)
Market Segmentation-
By Procedure Type
Needle Breast Biopsy
Core-needle Biopsy
Fine-needle Aspiration Biopsy
Vacuum-assisted Biopsy
Open Surgical Breast Biopsy
Excisional Breast Biopsy
Incisional Breast Biopsy
By Procedure Type
Needle Breast Biopsy
Core-needle Biopsy
Fine-needle Aspiration Biopsy
Vacuum-assisted Biopsy
Open Surgical Breast Biopsy
Excisional Breast Biopsy
Incisional Breast Biopsy
By Product
Guidance Systems
Biopsy Tables
Localization Wires
Biopsy Needles
Others (Punches, Markers, Sutures)
Guidance Systems
Biopsy Tables
Localization Wires
Biopsy Needles
Others (Punches, Markers, Sutures)
By Guidance Type
Ultrasound-guided Breast Biopsy
Mammography-guided Stereotactic Breast Biopsy
Magnetic Resonance-guided Breast Biopsy
Others (thermography, PET)
Ultrasound-guided Breast Biopsy
Mammography-guided Stereotactic Breast Biopsy
Magnetic Resonance-guided Breast Biopsy
Others (thermography, PET)
Major Table of Contents:
Chapter 1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
Chapter 1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
Chapter 2. Executive Summary
2.1. Key Highlights
2.1. Key Highlights
Chapter 3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Breast Biopsy Devices Market, By Procedure Type
5. Breast Biopsy Devices Market, By Product
6. Breast Biopsy Devices Market, By Guidance Type
7. Breast Biopsy Devices Market, By Region
…….CONTINUED FOR TOC
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Breast Biopsy Devices Market, By Procedure Type
5. Breast Biopsy Devices Market, By Product
6. Breast Biopsy Devices Market, By Guidance Type
7. Breast Biopsy Devices Market, By Region
…….CONTINUED FOR TOC
List of Tables
Table 1.Breast Biopsy Devices Market, By Procedure Type ($Million), 2012-2022
Table 2.Needle Breast Biopsy Market, By Region ($Million), 2012-2022
Table 3.Core-needle Biopsy Market, By Region ($Million), 2012-2022
Table 4.Fine-needle Aspiration Biopsy Market, By Region ($Million), 2012-2022
Table 5.Vacuum-assisted Biopsy Market, By Region ($Million), 2012-2022
Table 1.Breast Biopsy Devices Market, By Procedure Type ($Million), 2012-2022
Table 2.Needle Breast Biopsy Market, By Region ($Million), 2012-2022
Table 3.Core-needle Biopsy Market, By Region ($Million), 2012-2022
Table 4.Fine-needle Aspiration Biopsy Market, By Region ($Million), 2012-2022
Table 5.Vacuum-assisted Biopsy Market, By Region ($Million), 2012-2022
List of Figures
Figure 1.Breast Biopsy Devices Market Share, By Procedure Type, 2012 & 2022 ($Million)
Figure 2.Breast Biopsy Devices Market, By Product, 2012 & 2022 ($Million)
Figure 3.Breast Biopsy Devices Market, By Guidance Type, 2012 & 2022 ($Million)
Figure 4.Breast Biopsy Devices Market, By Region, 2016, ($Million)
Figure 5.C. R. Bard, Inc.: Net Revenues, 2014-2016 ($Million)
Figure 6.C. R. Bard, Inc.: Net Revenue Share, By Segment, 2016
Figure 1.Breast Biopsy Devices Market Share, By Procedure Type, 2012 & 2022 ($Million)
Figure 2.Breast Biopsy Devices Market, By Product, 2012 & 2022 ($Million)
Figure 3.Breast Biopsy Devices Market, By Guidance Type, 2012 & 2022 ($Million)
Figure 4.Breast Biopsy Devices Market, By Region, 2016, ($Million)
Figure 5.C. R. Bard, Inc.: Net Revenues, 2014-2016 ($Million)
Figure 6.C. R. Bard, Inc.: Net Revenue Share, By Segment, 2016
To Check an Discount of This Precious Report @
https://www.crystalmarketresearch.com/check-discount/CM10250
https://www.crystalmarketresearch.com/check-discount/CM10250
About Crystal Market Research:
Crystal Offers One Stop Solution For Market Research, Business Intelligence, And Consulting Services To Help Clients Make More Informed Decisions. It Provides Both Syndicated As Well As Customized Research Studies For Its Customers Spread Across The Globe. The Company Offers Market Intelligence Reports Across A Broad Range Of Industries Including Healthcare, Chemicals & Materials, Technology, Automotive, And Energy.
Crystal Offers One Stop Solution For Market Research, Business Intelligence, And Consulting Services To Help Clients Make More Informed Decisions. It Provides Both Syndicated As Well As Customized Research Studies For Its Customers Spread Across The Globe. The Company Offers Market Intelligence Reports Across A Broad Range Of Industries Including Healthcare, Chemicals & Materials, Technology, Automotive, And Energy.
Contact Us:
Judy S,
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Email: Sales@Crystalmarketresearch.Com
Judy S,
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Email: Sales@Crystalmarketresearch.Com
No comments:
Post a Comment